A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas
Status:
Completed
Trial end date:
2016-12-28
Target enrollment:
Participant gender:
Summary
This study is for patients who have been diagnosed with soft tissue sarcoma that has spread
(metastasized) or that is not eligible for removal by surgery. The purpose of this study is
to determine how soft tissue sarcomas respond to treatment with an investigational drug
called tivozanib. In some lab and clinical studies, tivozanib has been shown to interfere
with the growth of some types of tumors. The study will also evaluate how safe the study
treatment is by observing how many and what kind of adverse events (side effects)
participants experience.